Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Randomized Phase 2 Study of FcRn Antagonist Efgartigimod in Generalized Myasthenia Gravis. Neurology 2025;104:e210299.
PMID: 39813633

Privacy Policy